Troponin level at presentation as a prognostic factor among patients presenting with non-ST-segment elevation myocardial infarction.

ABSTRACT:

Background

Timely reperfusion within 120 min is strongly recommended in patients presenting with non-ST-segment myocardial infarction (NSTEMI) with very high-risk features. Evidence regarding the use of high-sensitivity cardiac troponin (hs-cTn) concentration upon admission for the risk-stratification of patients presenting with NSTEMI to expedite percutaneous coronary intervention (PCI) and thus potentially improve outcomes is limited.

Methods

All patients admitted to a tertiary care center ICCU between July 2019 and July 2022 were included. Hs-cTnI levels on presentaion were recorded, dividing patients into quartiles based on baseline hs-cTnI. Association between initial hs-cTnI and all-cause mortality during up to 3 years of follow-up was studied.

Results

A total o

SUBMITTER: Loutati R 

PROVIDER: S-EPMC10766125 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature